CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | RUBINSTEIN JULIE President | Sale | −25,580 | $3.43 | $88K | 486,244 |
| 2024-03-05 | RUBINSTEIN JULIE President | Sale | −13,490 | $3.56 | $48K | 472,754 |
| 2024-03-05 | PETERSON TYCHO Chief Financial Officer | Sale | −15,456 | $3.44 | $53K | 531,553 |
| 2024-03-05 | ROBINS CHAD M CEO and Chairman | Sale | −5,879 | $3.44 | $20K | 2,619,495 |
| 2024-03-05 | ROBINS CHAD M CEO and Chairman | Sale | −42,794 | $3.43 | $147K | 2,576,701 |
| 2024-03-05 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | −6,016 | $3.43 | $21K | 255,265 |
| 2024-03-05 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | −6,975 | $3.44 | $24K | 248,290 |
| 2024-03-04 | Pellini Michael J Director | Grant or award | +31,328 | 54,296 | ||
| 2024-03-04 | Pellini Michael J Director | Grant or award · Stock Option (right to buy) | +48,044 | 48,044 | ||
| 2024-03-04 | OWEN KATEY EINTERZ Director | Grant or award | +31,328 | 57,235 | ||
| 2024-03-04 | OWEN KATEY EINTERZ Director | Grant or award · Stock Option (right to buy) | +48,044 | 48,044 | ||
| 2024-03-04 | NEUPERT PETER M Director | Grant or award | +31,328 | 154,296 | ||
| 2024-03-04 | NEUPERT PETER M Director | Grant or award · Stock Option (right to buy) | +48,044 | 48,044 | ||
| 2024-03-04 | HERSHBERG ROBERT Director | Grant or award | +31,328 | 107,296 | ||
| 2024-03-04 | HERSHBERG ROBERT Director | Grant or award · Stock Option (right to buy) | +48,044 | 48,044 | ||
| 2024-03-04 | GRIFFIN MICHELLE RENEE Director | Grant or award | +31,328 | 51,955 | ||
| 2024-03-04 | GRIFFIN MICHELLE RENEE Director | Grant or award · Stock Option (right to buy) | +48,044 | 48,044 | ||
| 2024-03-04 | PISKEL KYLE Principal Accounting Officer | Grant or award | +43,740 | 131,045 | ||
| 2024-03-04 | Taylor Stacy L SVP and General Counsel | Grant or award | +39,990 | 179,668 | ||
| 2024-03-04 | Taylor Stacy L SVP and General Counsel | Grant or award · Stock Option (right to buy) | +60,010 | 60,010 |
Page 30 of 120 · 2,386 trades